Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hartmut Koeppen

Showing results (51-60 of 147) with videos related to

Pageof 15
Sort By:
Cancer Research|October 22, 2009
Pegylated kunitz domain inhibitor suppresses hepsin-mediated invasive tumor growth and metastasisWei Li, Bu-Er Wang, Paul Moran, et al.
Cancer Research|November 4, 2005
Maternal embryonic leucine zipper kinase/murine protein serine-threonine kinase 38 is a promising therapeutic target for multiple cancersDaniel Gray, Adrian M Jubb, Deborah Hogue, et al.
Plos One|May 12, 2011
TMEFF2 is a PDGF-AA binding protein with methylation-associated gene silencing in multiple cancer types including gliomaKui Lin, James R Taylor, Thomas D Wu, et al.
Mabs|February 27, 2016
Preclinical pharmacokinetics, pharmacodynamics, tissue distribution, and tumor penetration of anti-PD-L1 monoclonal antibody, an immune checkpoint inhibitorRong Deng, Daniela Bumbaca, Cinthia V Pastuskovas, et al.
Journal of the National Cancer Institute|July 7, 2005
Association of k-ras, b-raf, and p53 status with the treatment effect of bevacizumabWilliam L Ince, Adrian M Jubb, Scott N Holden, et al.
Cancer Research|May 19, 2007
Armed antibodies targeting the mucin repeats of the ovarian cancer antigen, MUC16, are highly efficacious in animal tumor modelsYoujun Chen, Suzanna Clark, Terence Wong, et al.
Molecular & Cellular Proteomics : MCP|April 24, 2013
Systems-wide analysis of K-Ras, Cdc42, and PAK4 signaling by quantitative phosphoproteomicsFlorian Gnad, Amy Young, Wei Zhou, et al.
Gut|May 29, 2012
In situ validation of an intestinal stem cell signature in colorectal cancerJennifer L Ziskin, Debra Dunlap, Murat Yaylaoglu, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|February 11, 2026
Characterization of an anti-STEAP1 T-Cell Dependent Bispecific Antibody for the Treatment of Prostate Cancer and Associated Toxicity in Cynomolgus MonkeysElizabeth G Tonkin, Michelle Lepherd, John Davies, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 28, 2014
High-throughput detection of clinically relevant mutations in archived tumor samples by multiplexed PCR and next-generation sequencingRichard Bourgon, Shan Lu, Yibing Yan, et al.
Pageof 15

Showing results (51-60 of 147) with videos related to

Sort By:
Pageof 15
Cancer Research|October 22, 2009
Pegylated kunitz domain inhibitor suppresses hepsin-mediated invasive tumor growth and metastasisWei Li, Bu-Er Wang, Paul Moran, et al.
Cancer Research|November 4, 2005
Maternal embryonic leucine zipper kinase/murine protein serine-threonine kinase 38 is a promising therapeutic target for multiple cancersDaniel Gray, Adrian M Jubb, Deborah Hogue, et al.
Plos One|May 12, 2011
TMEFF2 is a PDGF-AA binding protein with methylation-associated gene silencing in multiple cancer types including gliomaKui Lin, James R Taylor, Thomas D Wu, et al.
Mabs|February 27, 2016
Preclinical pharmacokinetics, pharmacodynamics, tissue distribution, and tumor penetration of anti-PD-L1 monoclonal antibody, an immune checkpoint inhibitorRong Deng, Daniela Bumbaca, Cinthia V Pastuskovas, et al.
Journal of the National Cancer Institute|July 7, 2005
Association of k-ras, b-raf, and p53 status with the treatment effect of bevacizumabWilliam L Ince, Adrian M Jubb, Scott N Holden, et al.
Cancer Research|May 19, 2007
Armed antibodies targeting the mucin repeats of the ovarian cancer antigen, MUC16, are highly efficacious in animal tumor modelsYoujun Chen, Suzanna Clark, Terence Wong, et al.
Molecular & Cellular Proteomics : MCP|April 24, 2013
Systems-wide analysis of K-Ras, Cdc42, and PAK4 signaling by quantitative phosphoproteomicsFlorian Gnad, Amy Young, Wei Zhou, et al.
Gut|May 29, 2012
In situ validation of an intestinal stem cell signature in colorectal cancerJennifer L Ziskin, Debra Dunlap, Murat Yaylaoglu, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|February 11, 2026
Characterization of an anti-STEAP1 T-Cell Dependent Bispecific Antibody for the Treatment of Prostate Cancer and Associated Toxicity in Cynomolgus MonkeysElizabeth G Tonkin, Michelle Lepherd, John Davies, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 28, 2014
High-throughput detection of clinically relevant mutations in archived tumor samples by multiplexed PCR and next-generation sequencingRichard Bourgon, Shan Lu, Yibing Yan, et al.
Pageof 15